2 months ago
1
To guarantee ethical pharmaceutical practices successful the proviso concatenation of value nonaccomplishment cause (GLP-1), the Drugs Controller of India has intensified its regulatory surveillance against the drug’s unauthorised merchantability and promotion.
“With the caller instauration of aggregate generic variants of GLP-1-based value nonaccomplishment drugs successful the Indian market, concerns person emerged regarding their on-demand availability done retail pharmacies, online platforms, wholesalers, and wellness clinics. These drugs, erstwhile utilized without due aesculapian supervision, whitethorn pb to superior adverse effects and related wellness risks,’’ said the Health Ministry successful a merchandise connected Tuesday (March 24, 2026).
Taking cognisance of the situation, India’s drugs controller, successful collaboration with State regulators, has initiated a bid of targeted actions to curb imaginable malpractices crossed the pharmaceutical proviso concatenation and forestall unauthorised income and use.
On March 10, a broad advisory was issued to each manufacturers, explicitly prohibiting surrogate advertisements and immoderate signifier of indirect promotion that could mislead consumers oregon promote off-label usage.
Audits, inspections
In the caller weeks, enforcement activities were importantly scaled up. Audits and inspections were conducted astatine 49 entities, including — online pharmacy warehouses, cause wholesalers, retailers, wellness and slimming clinics.
These inspections spanned aggregate regions crossed the state and focused connected identifying violations related to unauthorised sale, improper medicine practices, and misleading marketing. Further, notices person besides been sent to defaulting entities.
The Regulator emphasises that diligent information remains paramount. “The misuse of value nonaccomplishment drugs without objective oversight tin pb to terrible wellness complications. Citizens are advised to usage specified medications lone nether the guidance of qualified aesculapian practitioners,’’ added the release.
It besides noted that these drugs person been approved successful India with information of medicine by endocrinologists and interior medicine specialists and for immoderate indications by cardiologists only.
Regulatory surveillance volition proceed to beryllium intensified successful the coming weeks and non-compliances volition beryllium dealt with actions, including cancellation of licences, penalties, and prosecution nether applicable laws, the Ministry has warned.
Monika Sharma, elder consultant, Endocrinology, Aakash Healthcare said the intensified regularisation was an indispensable measurement to guarantee the cause gets utilized by the close patients.
“Excessive and improper usage carries a existent hazard of complications specified arsenic gall bladder stones, risk of dehydration and macromolecule malnutrition. Ensuring that the cause is disposable connected medicine by a qualified aesculapian nonrecreational volition guarantee that nationalist wellness is ensured,” helium said.
